200 related articles for article (PubMed ID: 29484670)
1. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
[TBL] [Abstract][Full Text] [Related]
2. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
[TBL] [Abstract][Full Text] [Related]
3. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation.
Thiele T; Kellner S; Hron G; Wasner C; Nauck M; Zimmermann K; Wessel A; Warkentin TE; Greinacher A; Selleng K
Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044
[TBL] [Abstract][Full Text] [Related]
4. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
Reichenberg S; Gravemann U; Sumian C; Seltsam A
Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
Wang D; Bu F; Xu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
[TBL] [Abstract][Full Text] [Related]
6. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices.
Depasse F; Sensebé L; Seghatchian J; Andreu G; Samama MM
Transfus Apher Sci; 2005 Aug; 33(1):63-9. PubMed ID: 16029868
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.
Thiele T; Hron G; Kellner S; Wasner C; Westphal A; Warkentin TE; Greinacher A; Selleng K
Blood Transfus; 2016 Jan; 14(1):66-72. PubMed ID: 26192785
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of vitamin C on protein activity in plasma during virus inactivation].
Li Y; Li MY; Jiang RJ; Jia WX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):392-6. PubMed ID: 16638223
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible light.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Vox Sang; 2020 Apr; 115(3):146-151. PubMed ID: 31930543
[TBL] [Abstract][Full Text] [Related]
10. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.
Zeiler T; Riess H; Wittmann G; Hintz G; Zimmermann R; Müller C; Heuft HG; Huhn D
Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485
[TBL] [Abstract][Full Text] [Related]
11. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
[TBL] [Abstract][Full Text] [Related]
12. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the hemostatic capacity of methylene blue-treated liquid (not frozen) plasma stored up 14 days at 2° to 6°C.
Rapaille A; Lotens A; de Valensart N; Najdovski T; Green L
Transfusion; 2021 Aug; 61(8):2450-2457. PubMed ID: 33913163
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
Cardigan R; Philpot K; Cookson P; Luddington R
Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
[TBL] [Abstract][Full Text] [Related]
17. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate.
Backholer L; Wiltshire M; Proffitt S; Cookson P; Cardigan R
Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252
[TBL] [Abstract][Full Text] [Related]
18. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
Moog R; Reichenberg S; Hoburg A; Müller N
Transfusion; 2010 Feb; 50(2):516-8. PubMed ID: 20233360
[No Abstract] [Full Text] [Related]
19. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
[TBL] [Abstract][Full Text] [Related]
20. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
